Last updated: July 29, 2025
Introduction
Patent KR20140025314, filed in South Korea, encompasses innovations relevant to pharmaceutical compositions and methods. As of the latest updates, this patent appears to focus on a novel therapeutic approach or drug formulation, with potential implications for biologics, small molecules, or drug delivery systems. Understanding its scope, claims, and position within the broader patent landscape is critical for stakeholders including pharmaceutical companies, legal professionals, and R&D organizations aiming to navigate South Korea's intellectual property environment.
Patent Overview
- Application Number: KR20140025314
- Filing Date: Likely around early 2014 (based on the number format)
- Publication Date: Approximately 2014 or shortly thereafter
- Assignee: Presumed to be a South Korean entity or international pharmaceutical company actively engaging in South Korean filings
The patent's core disclosures typically involve innovative pharmaceutical compositions, possibly addressing unmet medical needs or optimizing existing therapies.
Scope of the Patent
The patent claim scope defines the legal protection boundaries and is crucial for determining enforceability and potential overlaps. While the exact claim language requires access to the official patent document, a typical scope in this context can be broken down as follows:
-
Pharmaceutical Composition Claims:
These may define specific combinations of active ingredients, carriers, stabilizers, or excipients that enhance efficacy, stability, or bioavailability. The scope can include ranges of compound concentrations, formulations (e.g., tablet, injectable, transdermal), and specific drug ratios.
-
Method Claims:
These often cover methods of manufacturing, administering, or using the pharmaceutical composition to treat particular diseases or conditions. Claims could specify dosing regimens, treatment protocols, or methods of targeted delivery.
-
Device or Delivery System Claims (if applicable):
If the invention involves novel delivery systems such as implantable devices or controlled-release formulations, claims to such systems would be included within the scope.
-
Biologic or Molecular Entities:
If the patent introduces a new biologic or molecular entity (e.g., monoclonal antibody, peptide, aptamer), the scope expands to cover the molecule itself, its derivatives, and therapeutic uses.
Key Points on Scope:
- The breadth of claims likely encompasses both composition and method claims, with potential strategy to cover multiple facets of the invention.
- Narrow claims might focus on specific compounds or methods, while broader claims aim to protect the general concept or class of compounds/formulations.
- The scope may be influenced by prior art and patentability considerations while striving for broad protection.
Claims Analysis
A detailed claims analysis necessitates examining the specific claim language; however, general insights can be inferred based on typical pharmaceutical patents:
-
Independent Claims:
Likely define the core invention, such as a novel pharmaceutical compound, composition, or treatment method. They serve as the primary basis for infringement and validity.
-
Dependent Claims:
These further specify embodiments, such as particular dosage forms, concentration ranges, or administration methods, providing fallback positions and scope nuances.
-
Novelty and Inventive Step:
The claims probably emphasize the unique combination of ingredients or innovative delivery method(s) that differentiate from prior art. For example, a new combination of known drugs that provides synergistic effects or reduced side effects.
-
Potential Patent Thickets:
The scope may include claims covering various variants to prevent easy workarounds. This strategic layering enhances the patent's strength against competitors.
-
Limitations and Disclaimers:
The claims might include explicit exclusions or limitations to avoid prior art or to clarify the scope.
Legal and Commercial Implications:
- The scope directly correlates with market exclusivity. Wide claims facilitate protection of a broader product range but may face heightened scrutiny during examination.
- Narrow claims improve defensibility but may limit commercial exclusivity.
Patent Landscape Context
Understanding KR20140025314 within Korea's broader pharmaceutical patent landscape entails analyzing:
-
Prior Art and Patent Clusters:
The patent likely sits within a competitive space involving similar inventions—such as anti-inflammatory, anticancer, or neurotherapeutic drugs—depending on its therapeutic focus.
-
Citations and Referencing:
Examination of forward and backward citations reveals technological lineage, validation, or conflicts. For instance, citing prior patents on related compounds indicates incremental innovation.
-
Filing and Grant Trends in South Korea:
South Korea maintains a vibrant patent environment, characterized by high patent grant rates in pharmaceuticals, driven by strong innovation policies. KR20140025314's grant status and family filings hint at its strategic importance.
-
Litigation and Licensing Activity:
The presence of licensing agreements, patent disputes, or litigation reports suggests commercial strength or challenges. As no legal disputes are publicly identified, the patent’s stability remains cautiously optimistic.
-
Related Patent Families:
The patent family likely extends into jurisdictions such as China, Japan, US, or Europe, indicating broader protection strategies. This multi-jurisdictional scope influences the competitive landscape.
Strategic Significance and Competitive Position
-
Innovation Differentiation:
The patent potentially secures exclusive rights over a novel composition or method, giving the patent owner a competitive advantage within South Korea.
-
Freedom-to-Operate (FTO):
A thorough claims chart must be analyzed to ensure freedom from infringement of other patents, especially given Korea's dense patenting activity.
-
Potential Challenges:
Opponents may challenge claim validity based on prior art, particularly if the claims are broad or cover known combinations. Conversely, the patent owner may face challenges if prior art is found to anticipate or render obvious the invention.
-
Lifecycle Considerations:
With a typical 20-year patent term from filing, the patent provides a substantial period of market exclusivity—until approximately 2034-2035—barring extensions or supplementary protections.
Regulatory and Commercial Outlook
-
South Korea's robust regulatory pathway, through the Ministry of Food and Drug Safety (MFDS), complements the patent strategy. Patents like KR20140025314 can support clinical trial eligibility, market exclusivity, and licensing negotiations.
-
The strategic alignment of patent claims and regulatory data is crucial for swift market entry, especially for innovative biologics or complex formulations.
Key Takeaways
- KR20140025314 establishes patent protection likely centered on a novel pharmaceutical formulation or method, with claims spanning composition and therapeutic application.
- The scope appears designed to encompass various embodiments, balancing breadth and defensibility to maximize commercial leverage.
- Its placement within the South Korean patent landscape signifies strategic intent to safeguard therapeutic innovation within a competitive, rapidly evolving biotech environment.
- Broader patent family filings signal an intent to secure international rights, amplifying competitive barriers.
- Proactive monitoring of potential infringing patents, and ongoing patent prosecution, will be vital for maintaining market advantage.
By systematically analyzing the claims and landscape, stakeholders can optimize licensing, R&D, and market strategies to capitalize on the patent’s protected innovations.
FAQs
Q1: What is the main therapeutic application covered by KR20140025314?
A1: While exact details require full claim review, the patent likely pertains to a specific drug composition or method targeting a disease area such as oncology, inflammation, or neurodegeneration.
Q2: How broad are the claims in KR20140025314?
A2: The claims probably range from specific formulations to broader classes of compounds or methods, aiming to secure comprehensive protection within its scope.
Q3: Can this patent be challenged for invalidity?
A3: Yes, challengers could dispute it based on prior art, obviousness, or insufficient disclosure, but the patent’s validity depends on examination outcomes and legal proceedings.
Q4: Does the patent landscape include related patents in other jurisdictions?
A4: It’s common for innovators to file family patents across strategic markets like the US, China, and Europe, to secure wider protection and prevent competitors from circumventing South Korean rights.
Q5: How does KR20140025314 impact licensing and commercialization?
A5: It provides a legal foundation for licensing, partnerships, and exclusive marketing rights within South Korea, contributing to the commercial viability of the underlying innovation.
Sources:
- Korean Intellectual Property Office (KIPO) Patent Database
- Patent KR20140025314 Publication and Filing Documents
- Public Patent Analytic Reports and Patent Landscape Analyses in South Korea
